Access Scientific's POWERWAND Midline IV Catheter Sets New Industry Standard for Power Injectabilty SAN DIEGO, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Access Scientific, LLC today announced validation of the POWERWAND® midline IV catheter for power-injectable capability up to 8ml/sec, 325 psi for up...

Proteon Therapeutics Announces Positive Long-Term Results From Phase 2 Study of Investigational New Drug Vonapanitase in Chronic Kidney Disease Patients Undergoing Surgical Creation of an Arteriovenous Fistula for Hemodialysis DALLAS and WALTHAM, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of...

Association for Vascular Access (AVA) Works with TV Worldwide to Launch the 'AVA TV' Internet TV Channel Washington, D.C., Aug. 13, 2014 (GLOBE NEWSWIRE) -- TV Worldwide, since 1999, a pioneering web-based global TV network, announced that it had teamed with the Association for Vascular Access (AVA)...